Safe harbours for the integration of new DNA in the human genome.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22129804.
- Also identified by DOI 10.1038/nrc3179.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Interactions between newly integrated DNA and the host genome limit the reliability and safety of transgene integration for therapeutic cell engineering and other applications. Although targeted gene delivery has made considerable progress, the question of where to insert foreign sequences in the human genome to maximize safety and efficacy has received little attention. In this Opinion article, we discuss 'genomic safe harbours' - chromosomal locations where therapeutic transgenes can integrate and function in a predictable manner without perturbing endogenous gene activity and promoting cancer.
Medical subject headings
- Genetic Therapy
- Genome, Human
- Neoplasms
- Virus Integration